Mosterd et al 2001
5
| Participants from Rotterdam population study screened for diagnosis or symptoms of HF | 5255 | 181 | The Nether-lands | 68.9 | 89 | 79 | 59 | –
|
Nielsen et al 2003
6
| Cross-sectional sample from three general practices, screened for participants with diagnosis or symptoms of HF | 2157 including control group (571) and heart disease but no HF (218) | 67 with community managed HF: 33 in hospital managed HF comparator | Denmark | 74.1 | –
| –
| 61 | –
|
Hobbs et al 2007
7
| Participants from UK general practice screened for HF | 6162 including 1062 at high risk for HF and 982 on diuretics at baseline | Previous clinical label of HF ( 782) | UK | 64.2 | –
| –
| 63 | –
|
Tsutsui et al 2007
8
| Data from The Cardiac Registry of Heart Failure in General Practice | 2685 | 1280 followed-up in hospital and 1405 by GP | Japan | 74 | 90.9 | –
| –
| –
|
Pons et al 2010
9
| Consecutive sample from outpatient HF clinic | 960 | All followed-up in outpatient cardiology clinic | Spain | 69 | 89.4 | –
| –
| –
|
Taylor et al 2012
10
| As per Hobbs et al 2007 paper:
7
10-year follow-up of ECHOES cohort | See above | See above | UK | 64.2 | –
| –
| –
| 26.7 |
Taylor et al 2017
11
| Survival analysis using UK primary care records from The Health Improvement Network | 54 313 | All with first diagnosis of HF | UK | 76.5 | 81.3 | –
| 51.5 | 29.5 |